Special Issue "Advances in circRNA Biology"
Deadline for manuscript submissions: closed (15 November 2023) | Viewed by 7928
Interests: colorectal cancer; leukemia; tumor biomarkers; circular RNA; tRNA fragments; transcriptomics; anticancer drugs; apoptosis; BCL2 family; alternative splicing.
Special Issues, Collections and Topics in MDPI journals
Special Issue in Genes: Alternative Splicing in Human Physiology and Disease
Special Issue in Biomedicines: MicroRNAs, tRNA Fragments, and Circular RNAs: Pivotal Regulators of Gene Expression and Their Roles in Human Diseases
Special Issue in International Journal of Molecular Sciences: The Role of MicroRNAs, tRNA Fragments, and Circular RNAs in Leukemia
Special Issue in Cells: Technologies and Applications of RNA Imaging
Special Issue in International Journal of Molecular Sciences: Alternative Splicing in Cancer: Role, Mechanisms and Impact
Topical Collection in Biomedicines: MicroRNAs, tRNA Fragments, Long Non-coding and Circular RNAs: Pivotal Regulators of Gene Expression and Their Roles in Human Physiology and Disease
Special Issue in Genes: Alternative Splicing and RNA Editing in Physiology and Disease
Special Issue in International Journal of Molecular Sciences: The Transcriptome Complexity in Cancer and Leukemia: Alternative Splicing and Beyond
Topical Collection in Cancers: Circular RNAs: New Insights into the Molecular Biology of Cancer
Circular RNAs (circRNAs) are a new RNA type, deriving from back-splicing. circRNAs have raised researchers’ interest due to their widespread expression and multifaceted role. More specifically, they can act as microRNA sponges, protein sponges or scaffolds, and encode for peptides. Additionally, they play regulatory roles in several cellular processes, including signaling and alternative splicing, both in physiological and pathological states. In particular, their expression has been associated with several aspects of cell life, for instance proliferation and migration, while several studies highlight their value as cancer biomarkers and therapeutic targets.
This Special Issue focuses on the information of the readers regarding the biogenesis and action mechanisms, targets and clinical utility of circRNAs in human physiological and pathological states, with emphasis on cancer, neurodegenerative, cardiovascular and other diseases. The authors are encouraged to submit their original research studies concerning this topic. Review articles will also be taken into consideration. The Guest Editor is willing to evaluate also manuscripts describing other aspects of circRNA Biology, proposed by the authors.
Dr. Christos K. Kontos
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- microRNA (miRNA)
- long non-coding RNA (lncRNA)
- alternative splicing
- regulation of signaling pathways
- therapeutic targets
- therapy resistance
- neurological diseases
- cardiovascular diseases